Submit to Special Issue Submit Abstract to Special Issue Review for Medicina Propose a Special Issue

Journal Browser

► Journal Browser

The Challenges and Prospects in Clinical Cardiology and Angiology

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 20 May 2024 | Viewed by 3313

Share This Special Issue

Special Issue Editors

Dr. Vincenzo Zaccone

E-Mail Website
Guest Editor

Internal and Subintensive Medicine, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy
Interests: endothelial cells; atherosclerosis; endothelial progenitor cells; deep vein thrombosis; pulmonary embolism; cardiovascular regenerative medicine; sepsis and septic shock
Special Issues, Collections and Topics in MDPI journals

Dr. Giulio Francesco Romiti

E-Mail Website
Guest Editor

Department of Translational and Precision Medicine, Sapienza University of Rome, 00161 Rome, Italy
Interests: antithrombotic treatment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiovascular diseases remain the leading cause of mortality worldwide, necessitating the continuous exploration of innovative diagnostic techniques, treatment strategies and preventive measures.

This Special Issue aims to delve into the multifaceted landscape of challenges and prospects that shape the practice of clinical cardiology and angiology in today's medical landscape. From the evolving understanding of complex pathophysiological mechanisms to the development of innovative diagnostic tools and therapeutic interventions, this collection of articles seeks to provide a comprehensive overview of the current state of clinical cardiology and angiology.

In this Special Issue, renowned experts and researchers will contribute their insights on a range of topics, including the identification and management of risk factors, breakthroughs in non-invasive imaging techniques, personalized approaches to treatment and the integration of digital health technologies in cardiovascular practice. By addressing these challenges head-on and exploring potential future directions, this collection aims to foster a deeper understanding of the dynamic field of cardiology and angiology, ultimately leading to improved patient outcomes and enhanced cardiovascular care.

We are seeking original research, reviews, case studies, clinical trials and opinion pieces exploring challenges and prospects in clinical cardiology and angiology. Innovative diagnostics, treatments, translational research and healthcare delivery topics are welcome, contributing to advancements in cardiovascular and vascular care.

You may choose our Joint Special Issue in JCM.

Dr. Vincenzo Zaccone
Dr. Giulio Francesco Romiti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

cardiology
angiology
cardiovascular diseases
vascular health
diagnostic techniques
treatment strategies
translational research

Published Papers (3 papers)

Download All Papers

Research

Jump to: Other

18 pages, 911 KiB

Open AccessArticle

Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis

by Marius Rus, Adriana Ioana Ardelean, Claudia Judea Pusta, Simina Crisan, Paula Marian, Liliana Oana Pobirci, Veronica Huplea, Alina Stanca Osiceanu, Gheorghe Adrian Osiceanu, Felicia Liana Andronie-Cioara and Madalina Ioana Guler

Medicina 2024, 60(1), 38; https://doi.org/10.3390/medicina60010038 - 25 Dec 2023

Viewed by 966

Abstract

Background and Objectives: The risk of developing cardiovascular diseases (CVD) in patients suffering from rheumatoid arthritis (RA) is two times higher compared to the general population. The objective of this retrospective study was to determine which cardiovascular complications can appear in men vs. women with rheumatoid arthritis. Early diagnosis and initiation of therapeutic measures to reduce the progression rate of rheumatoid arthritis, while also maintaining an active lifestyle, are the most important problems in young patients. Materials and Methods: We included a number of 200 patients, divided into two groups according to gender (124 women and 76 men) with rheumatoid arthritis, presenting various stages of disease concomitant with cardiovascular complications. We assessed traditional and non-traditional risk factors, as well as electrocardiographic and echocardiographic findings in both groups. Results: All patients presented an atherogenic coefficient over two, indicating a significant risk of atherogenesis. Men had elevated levels of total cholesterol compared with women (≥200 mg/dL; 77.6%—men vs. 25.8%—women, p < 0.001). The participants presented cardiac arrhythmias, especially in the active stage of RA. Women had an increased risk of atrial fibrillation by 2.308 times compared to men (p = 0.020). One of the most important complications found in young women was pulmonary arterial hypertension (p = 0.007). Conclusions: In daily clinical practice, the screening of RA is carried out in sufficiently. This disease is often undiagnosed, and the risk factors remain unassessed. As a result, RA patients continue to present an increased risk of developing CVD. Full article

(This article belongs to the Special Issue The Challenges and Prospects in Clinical Cardiology and Angiology)

► Show Figures

Figure 1

9 pages, 1912 KiB

Open AccessArticle

Echo Intensity of Gastrocnemius Is Independently Associated with 6-Minute Walking Distance in Male Patients with Peripheral Arterial Disease

by Satoshi Yuguchi, Yusuke Ochi, Yukari Sagata, Mitsuhiro Idesako, Shino Maeda, Ryoma Asahi and Masahito Taniguchi

Medicina 2023, 59(11), 1894; https://doi.org/10.3390/medicina59111894 - 26 Oct 2023

Viewed by 1020

Abstract

Background and Objectives: This study aimed to examine the differences in the thickness and echo intensity (EI) of the gastrocnemius muscle measured via ultrasonography between healthy adults and patients with peripheral arterial disease (PAD) and to determine the associations of gastrocnemius thickness (GT) and EI within a 6 min walking distance (6MD) in patients with PAD. Materials and Methods: This cross-sectional study targeted 35 male patients with PAD (mean age, 73.7 years; mean body mass index [BMI], 23.5 kg/m²) and age- and gender-matched 73 male healthy adults (mean age, 73.2 years; mean BMI, 23.3 kg/m²). The gastrocnemius thickness (GT) and EI were measured using ultrasound. Both legs of patients with PAD were classified based on higher and lower ankle brachial pressure index (ABI), and the GTs and EIs with higher and lower ABI were compared with those of healthy adults. Multiple regression analysis incorporated 6MD as a dependent variable and each GT and EI with higher and lower ABI, age, and BMI as independent variables. Results: This study showed that GT was considerably greater in healthy adults than in both legs with higher and lower ABI (median values, 13.3 vs. 11.3 vs. 10.7, p < 0.01), whereas EI was lower in healthy adults than in the lower ABI leg (72.0 vs. 80.8 vs. 83.6, p < 0.05). The 6MD was shown to be substantially related to EI in both legs with higher and lower ABIs (p < 0.01) but not in the GT. Conclusions: In patients with PAD, the GT was lower, and EI was higher than in healthy adults. In addition, EIs in both legs with higher and lower ABIs were independently associated with 6MD in male PAD patients. This study showed that the EI measured via ultrasonography could become an important indicator for treatments for patients with PAD. Full article

(This article belongs to the Special Issue The Challenges and Prospects in Clinical Cardiology and Angiology)

► Show Figures

Figure 1

Other

Jump to: Research

0 pages, 2327 KiB

Open AccessSystematic Review

One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis

by Konstantinos Tigkiropoulos, Spyridon Nikas, Abatzis-Papadopoulos Manolis, Katerina Sidiropoulou, Kyriakos Stavridis, Dimitrios Karamanos, Ioannis Lazaridis and Nikolaos Saratzis

Medicina 2024, 60(2), 286; https://doi.org/10.3390/medicina60020286 - 08 Feb 2024

Viewed by 1013

Abstract

Background: Prospective single and multicenter studies have shown improved outcomes of patients who underwent carotid artery stenting with the novel CGuard dual-layer mesh stent at 1 year. Objectives: The aim of this study is to conduct a systematic review and meta-analysis of all published studies to assess 1-year efficacy and outcomes of CGuard in patients with carotid stenting. Methods: A systematic search was performed. All studies enrolling at least 20 patients were included in our analysis. The primary endpoints were death (all-cause, cardiovascular and ipsilateral stroke-related death) and stroke rate at 1 year. The secondary endpoint was in-stent restenosis at 1 year. Results: The final analysis included 1709 patients. The one-year all-cause mortality rate was 2.97% (39/1699, 95% CI: 1.26–6.86%, I² = 67%, t² = 0.3442, p < 0.01), cardiovascular-related death was 0.92% (10/1616, 95% CI: 0.35–2.39%, I² = 34%, t² = 0.2302, p = 0.18), and ipsilateral stroke-related death was 0.3% (1/1649, 95% CI: 0.1–0.87%, I² = 0%, t² = 0, p = 0.69). The one-year ipsilateral stroke rate was 1.21% (16/1649, 95% CI: 0.58–2.5%, I² = 28%, t² = 0.1433, p = 0.23), transient ischemic attacks (TIAs) rate was 1.78% (19/1149, 95% CI: 1.11–2.84%, I² = 0%, t² = 0, p = 0.69), and total composite 1-year stroke/TIA rate was 2.97% (32/1149, 95% CI: 1.84–4.77%, I² = 0%, t² = 0, p = 0.41). The in-stent restenosis rate at 1 year was 1.06% (13/1653, 95% CI: 0.48–2.34%, I² = 28%, t² = 0.2308, p = 0.22). Conclusions: This meta-analysis shows that CAS with CGuard is safe with minimal neurological adverse events and in-stent restenosis rate at 1 year. Full article

(This article belongs to the Special Issue The Challenges and Prospects in Clinical Cardiology and Angiology)

► Show Figures